Trade Ideas
Actionable trade ideas with entry/stop/target and risk framing.
Applied Materials: Buy the AI-Capex Upside into Q1 2026 — Tactical Long
Strong cash flow, improving margins and an AI-driven equipment cycle justify a buy-on-weakness trade ahead of the Q1 2026 print.
Applied Materials (AMAT) is positioned to benefit from renewed semiconductor capex tied to AI CPUs and GPUs. The stock has already run but fundamental...
Emcor: The Post-Surge Reset Is Healthy — Lean Long With Defined Risk
Strong cash conversion, accretive M&A and a surprising dividend bump keep upside intact even after last year’s rally
EMCOR Group (EME) has had a dramatic run — the headline fireworks are behind it, but the business fundamentals and recent corporate actions still su...
Pan American Silver (PAAS) - Downgrade: Short-Term Risk > Reward After Recent Meltup
Immediate trade: short into the post-rally pullback — structural exposure to metal prices and deal execution make this a high-risk short
Pan American Silver (PAAS) sold off sharply intraday, creating a tactical short opportunity. The company is a large diversified silver/gold miner with...
Exxon Mobil: The Operating Machine You Buy for Cash, Not Just Crude
High, predictable cash flow, growing production and a shareholder-friendly payout make XOM a pragmatic position trade today
Exxon Mobil is delivering consistent operating cash, volume-led resilience to lower oil prices and active capital returns. Given a reasonable valuatio...
AppFolio: Buy the Dip — Quality SaaS Cash Flow Meets Multiple Compression
Q4 results and headlines pushed APPF below key technical levels. Fundamentals and cash conversion argue for a tactical long with a disciplined stop.
AppFolio (APPF) fell sharply after recent trading and now offers a disciplined buying opportunity. The company is growing revenue >20% YoY, producing ...
Hims & Hers: Platform Pivot Looks Priced for Growth — Trade Idea to Ride the Re-Rate
Telehealth + pharmacy + GLP-1 exposure — a platform play where economics are starting to show up in the numbers
Hims & Hers (HIMS) is executing a shift from single-product DTC telehealth into a subscription-driven healthcare platform. Recent quarters show scale,...
Moderna vs. Novavax: Which Pandemic Pioneer Actually Deserves Your Risk Capital Today?
A focused trade idea on MRNA after the COVID-era rerate — anatomy of the balance sheet, revenue trajectory, and an entry/stop/target framework.
Moderna (MRNA) is a platform company trying to re-price from pandemic-era multiples into a multi-indication biotech. The stock is volatile, the busine...
Kaspi: The Real Growth Is Mobile Commerce, Not P2P — A Tactical Long
Buy the asymmetric setup as the Super App monetizes m-commerce while headline P2P noise keeps the stock discounted
Kaspi’s underlying transition from a P2P/payments narrative to durable m-commerce monetization is underappreciated. With the ADS trading near $79 an...
Newmont: Buy the Dip as Cash Flow, Deleveraging and Acquisition Upside Come into Focus
Short-term pullback creates an asymmetric trade — strong cash generation, a healthier balance sheet and visible growth make a decent risk/reward for a tactical long.
Newmont (NEM) pulled back ~5.5% intraday, offering an entry into a company generating >$2.2B quarterly in operating cash flow, shrinking long-term deb...
Buy the Rebound: HubSpot (HUBS) — Q3 Beat, Cash Flow and Buybacks Support a Swing Long
Out-of-favor multiple, improving cash generation and positive operating swing create a tactical long with defined risk.
HubSpot just delivered a clean Q3 (fiscal) beat with revenue of $809.5M and positive operating income; cash from operations is strong and the company ...
Buy Molina on the Medicare Overreaction: A Tactical Dip Trade
CMS proposes flat Medicare Advantage 2027 increases; market sells insurers broadly — Molina's Medicaid-heavy mix looks mispriced.
Molina (MOH) fell with the rest of the insurer complex after CMS floated modest to flat Medicare Advantage payment guidance for 2027. That pain is con...
TXO Partners: Low Net Leverage, High Distribution — A Trade for Income-Seekers with a Commodity Tilt
Buying TXO around $12 for a swing trade: attractive yield, conservative balance sheet, clear entry/stop/targets.
TXO Partners (TXO) is currently trading near $12 with an implied market value roughly $670M, carrying modest net debt against more than $1.37B in asse...